Global Human Brucella ELISA Kits Market Forecast 2026: Revenue Insights According to a newly published market research report by 24LifeSciences, global Human Brucella ELISA Kits market was valued at USD 75.6 million in 2024 and is projected to reach USD 118.2 million by 2032, growing at a compound annual growth rate (CAGR) of 5.4% during the forecast period 2025–2032. Download a Free Sample Report (PDF): https://www.24lifesciences.com/download-sample/962/search/q=Human+Brucella+ELISA+Kits+Market'

How Rapid and Molecular Diagnostics Are Shaping the Brucellosis Test Kits Market According to a newly published market research report by 24LifeSciences, global brucellosis test kits market is valued at USD 315.7 million in 2026 and is projected to reach USD 458.6 million by 2034, growing at a compound annual growth rate (CAGR) of 4.5% during the forecast period. Brucellosis test kits are in-vitro diagnostic (IVD) tools designed for the serological detection of antibodies against Brucella bacteria, a critical component in diagnosing both human and animal brucellosis. These kits play an essential role in managing this zoonotic disease, which causes significant economic losses in livestock production and poses serious public health risks. The most common formats include Brucella IgG, IgM, and IgA ELISA kits, along with traditional methods like rose bengal plate tests (RBPT) and advanced fluorescence polarization assays (FPA). Their accuracy and reliability make them indispensable for veterinary diagnostics, food safety programs, and human healthcare systems worldwide. Download a Free Sample Report (PDF): https://www.24lifesciences.com/download-sample/9628/brucellosis-test-kits-market